Skip to main content
. 2021 Feb 8;14(2):e238037. doi: 10.1136/bcr-2020-238037

Figure 3.

Figure 3

CT scan of the head before nivolumab (A) and after seven cycles of nivolumab (B). A 22 mm lesion in the left occipital region (arrowed) has resolved with some scarring within this period.